Relmada Therapeutics has a 12-month low of $0.24 and a 12-month high of $6.38. The firm’s fifty day moving average is $0.35 and its 200 day moving average is $1.82.

In a challenging year for Relmada Therapeutics (NASDAQ:RLMD), the company's stock has plummeted to a 52-week low, trading at ...

Relmada Therapeutics has Commenced a Process to Explore Strategic Alternatives to Maximize Shareholder ValueCORAL GABLES, Fla., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: ...

BioSpace remembers COVID-19 five years after the pandemic was declared, Novo Nordisk’s CagriSema again misses expectations as the company joins a lawsuit filed by drug compounders against the FDA, ...

They suggest other fast-acting antidepressants could offer a competitive challenge to J&J's drug, including Axsome Therapeutics' recently approved Auvelity (bupropion/dextromethorphan), Sage ...

After hours: March 10 at 7:37:16 PM EDT Loading Chart for RLMD ...

As of 3:58:27 PM EST. Market Open.

After hours: March 11 at 7:02:40 p.m. EDT Loading Chart for RLMD ...

After hours: 7 March at 18:59:07 GMT-5 ...